首页 | 本学科首页   官方微博 | 高级检索  
检索        

重组人白介素-10对大鼠血管平滑肌细胞增殖和细胞周期的影响
引用本文:欧阳平,彭立胜,彭文烈,赖文岩,杨红,吴文言,徐安龙.重组人白介素-10对大鼠血管平滑肌细胞增殖和细胞周期的影响[J].中国药理学通报,2002,18(2):190-193.
作者姓名:欧阳平  彭立胜  彭文烈  赖文岩  杨红  吴文言  徐安龙
作者单位:中山大学生命科学学院,广州,510275
基金项目:广州市科委科技攻关项目资助课题 NoJB0 0 0 0 0 44 8165
摘    要:目的 观察重组人白介素 10 (rhIL 10 )分别对肿瘤坏死因子 (TNF α)和血小板源性生长因子 (PDGF BB)刺激下离体大鼠胸主动脉血管平滑肌细胞增殖和细胞周期的影响。方法 体外培养大鼠胸主动脉血管平滑肌细胞 ,采用MTS/PES法确定血管平滑肌细胞的增殖状态 ,应用流式细胞术测定细胞周期。结果 与对照组相比 ,肿瘤坏死因子和血小板源性生长因子均对血管平滑肌细胞增殖具有明显的刺激作用 (P <0 0 5 )。rhIL 10单独应用对血管平滑肌细胞生长没有影响 (P >0 0 5 )。在TNF α和血小板源性生长因子分别刺激下 ,rhIL 10均可抑制血管平滑肌细胞的生长(P <0 0 5 )。流式细胞术测定的结果显示rhIL 10分别可以使TNF α和PDGF BB作用下的VSMCs大部分处于G0 /G1期 ,与对照组相比差异有显著性 (P <0 0 1)。结论 重组人白介素 10可抑制细胞因子和生长因子诱导的血管平滑肌细胞增殖

关 键 词:血管平滑肌细胞  重组白介素10  生长因子  细胞因子  细胞增殖
文章编号:1001-1978(2002)02-0190-04
修稿时间:2001年7月13日

Effects of recombinant human recombinant interleukin-10 on proliferation and cell cycle of rat vascular smooth muscle cells
OU YANG Ping,PENG Li Sheng,PENG Wen Lie,LAI Wen Yan ,YANG Hong,WU Wen Yan,XU An Long.Effects of recombinant human recombinant interleukin-10 on proliferation and cell cycle of rat vascular smooth muscle cells[J].Chinese Pharmacological Bulletin,2002,18(2):190-193.
Authors:OU YANG Ping  PENG Li Sheng  PENG Wen Lie  LAI Wen Yan  YANG Hong  WU Wen Yan  XU An Long
Institution:OU YANG Ping,PENG Li Sheng,PENG Wen Lie,LAI Wen Yan 1,YANG Hong,WU Wen Yan,XU An Long
Abstract:AIM To determine the effects of recombinant human interleukin 10 (rhIL 10) on rat vascular smooth muscle cells (VSMCs) proliferation by platelet derived growth factor and tumor necrosis factor α. METHODS Rat aortic VSMCs were cultured and treated with rhIL 10 or tumor necrosis factor α (TNF α) or platelet derived growth factor BB (PDGF BB) respectively. Proliferation was quantified by colormetric assay. Cell cycle analysis was performed by flow cytomertry. RESULTS Compared with control, TNF α and PDGF BB can stimulated VSMCs proliferation,respectively. rhIL 10 alone had no effect on VSMCs growth. With TNF α stimulation, rhIL 10, at dose as low as 10 μg·L -1 , inhibited VSMCs growth ( P< 0 05). With PDGF BB stimulation, rhIL 10, at dose as low as 10 ng·L -1 , inhibited VSMCs growth ( P< 0 05). Cell number in G 0/G 1 phase of PDGF BB and rhIL 10 co treatment group was higher than those of PDGF BB group ( P< 0 01) by flow cytometry analysis. The same results were observed in TNF α and rhIL 10 co treatment group ( P< 0 01). CONCLUSION The class Ⅱ cytokine receptor ligand, IL 10, inhibits TNF α and PDGF BB induced VSMCs proliferation, respectively. The class Ⅱ cytokine receptor may provide a novel therapeutic target in regulating vessel wall remodeling after vascular injury.
Keywords:vascular smooth muscle cells  recombinant interleukin  10  growth factor  cytokine  cell proliferation
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号